Rising serum CA-125 levels within the normal range is strongly associated recurrence risk and survival of ovarian cancer

• Autors principals: Szymon Piatek (Autor), Grzegorz Panek (Autor), Zbigniew Lewandowski (Autor), Mariusz Bidzinski (Autor), Dominika Piatek (Autor), Przemyslaw Kosinski (Autor), Miroslaw Wielgos (Autor)
• Format: Llibre
• Publicat: BMC, 2020-09-01T00:00:00Z.
• Matèries: article
• Accés en línia: Connect to this object online.

Abstract Background In clinical practice alterations in CA-125 concentration within normal range in patients with ovarian cancer after first-line treatment are common. Even minor increase in CA-125 concentration is associated with patients' anxiety and difficult interpretation and counselling f...